Vivos therapeutics announces closing of initial public offering and exercise in full of the underwriters' option to purchase additional shares

Highlands ranch, colo., dec. 15, 2020 (globe newswire) -- vivos therapeutics, inc. (“vivos”) today announced the closing of its initial public offering of 4,025,000 shares of its common stock. the offering consisted of 3,500,000 shares of its common stock, as well as an additional 525,000 shares pursuant to the exercise in full of the underwriters' option to purchase additional shares of common stock, at a public offering price of $6.00 per share. vivos' common stock is listed on the nasdaq capital market under the ticker symbol “vvos.”
VVOS Ratings Summary
VVOS Quant Ranking